Table 1 Clinical characteristics of studied population (n = 108)
From: A cohort study of membranous nephropathy, primary or secondary
| Parameter | p value | |
|---|---|---|
| Age (years) | 44.21±13.32 | |
| Gender (male) | 66 (61.1%) | |
| Diabetes | 11 (10.2%) | |
| HTN | 68 (63%) | |
| Immunosuppressive treatment | ACEi/ARB administration | 91(84.3%) |
| PDN + CNI | 61 (59.2%) | |
| PDN + CNI + MMF | 9 (8.7%) | |
| Rituximab | 2 (1.9%) | |
| Ponticelli regimen | 10 (9.7%) | |
| PDN | 7 (6.8%) | |
| None | 14 (13.6%) |